Akanda Yönetim
Yönetim kriter kontrolleri 1/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Katie Field
İcra Kurulu Başkanı
US$112.0k
Toplam tazminat
| CEO maaş yüzdesi | 100.0% |
| CEO görev süresi | 1.8yrs |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 2.2yrs |
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$32m |
| Mar 31 2024 | n/a | n/a | -US$32m |
| Dec 31 2023 | US$112k | US$112k | -US$32m |
| Sep 30 2023 | n/a | n/a | -US$24m |
| Jun 30 2023 | n/a | n/a | -US$12m |
| Mar 31 2023 | n/a | n/a | -US$10m |
| Dec 31 2022 | US$70k | US$35k | -US$8m |
Tazminat ve Piyasa: Katie's total compensation ($USD111.97K) is below average for companies of similar size in the US market ($USD655.65K).
Tazminat ve Kazançlar: Katie's compensation has increased whilst the company is unprofitable.
CEO
Katie Field (41 yo)
1.8yrs
Görev süresi
US$111,968
Tazminat
Ms. Katharyn Field, also known as Katie, serves as an Independent Chairman of the Board of iSpecimen Inc. since September 2024. She is Independent Director of Virpax Pharmaceuticals, Inc. from July 2024. M...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Interim CEO & Executive Director | 2.3yrs | US$111.97k | Veri yok | |
| Independent Director | less than a year | Veri yok | Veri yok | |
| Chair of Advisory Board | 2.2yrs | Veri yok | Veri yok | |
| Independent Director | 2.3yrs | US$111.97k | Veri yok | |
| Independent Director | 1.8yrs | US$79.95k | Veri yok |
2.2yrs
Ortalama Görev Süresi
43yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: AKAN's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.